GLP-1 Market
LLY $1136.11 ▼ -0.2% NVO $42.53 ▼ -2.1% PFE $27.55 ▼ -0.6% VKTX $29.95 ▼ -5.0% KLRA $13.45 ▼ -2.2% GPCR $38.95 ▲ +1.3% RHHBY $54.90 ▲ +0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Estrone

Company
Khyber Medical University Peshawar
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
58 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

58 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Estrone and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02476786

    Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

    Not yet reported Washington University School of Medicine 50 participants Est. completion 2032-07-31 1 site
    Other conditions: Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the Breast
    View official trial listing →
  • Recruiting NCT NCT03011684

    Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial

    Not yet reported University of California, San Francisco 309 participants Est. completion 2028-03-31 1 site
    Other conditions: Infertility
    View official trial listing →
  • Recruiting NCT NCT03624244

    Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

    Not yet reported Centre Leon Berard 40 participants Est. completion 2031-01 22 sites
    Other conditions: Low Grade Endometrial Stromal Sarcoma
    View official trial listing →
  • Recruiting NCT NCT04113993

    Bazedoxifene -Treatment for Women With Schizophrenia

    Not yet reported The Alfred 160 participants Est. completion 2026-12-31 1 site
    Other conditions: Schizophrenia, Schizophreniform Disorders, Schizo Affective Disorder
    View official trial listing →
  • Recruiting NCT NCT04439370

    Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women

    University of Minnesota 160 participants Est. completion 2026-12-30 1 site
    Other conditions: Hypertension, Menopause, Premature, Menopause, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT04596592

    Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

    University of Colorado, Denver 90 participants Est. completion 2026-07-31 1 site
    Other conditions: Transgenderism, Gender Dysphoria, Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT04812912

    Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

    Memorial Sloan Kettering Cancer Center 120 participants Est. completion 2027-03-18 7 sites
    Other conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05280028

    HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

    Far Eastern Memorial Hospital 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Recruiting NCT NCT05282277

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

    Not yet reported University of North Carolina, Chapel Hill 103 participants Est. completion 2026-12-31 1 site
    Other conditions: Depression, Psychosis, Anhedonia
    View official trial listing →
  • Recruiting NCT NCT05305924

    Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

    Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2027-12-01 1 site
    Other conditions: ER-Positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05325632

    Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 53 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05333328

    OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

    Not yet reported Gangnam Severance Hospital 418 participants Est. completion 2033-01 2 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer, Premenopausal Breast Cancer, Node-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05343572

    Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

    Not yet reported Hugh Taylor 90 participants Est. completion 2027-12 1 site
    Other conditions: Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure
    View official trial listing →
  • Recruiting NCT NCT05608252

    VS-6766+Abema+Fulv in Met HR+/HER- BC

    Not yet reported, Not yet reported Adrienne G. Waks 63 participants Est. completion 2028-12-31 3 sites
    Other conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05683418

    A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

    Not yet reported Totus Medicines 241 participants Est. completion 2027-12 18 sites
    Other conditions: HR+/HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05901428

    TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

    Not yet reported Fudan University 1736 participants Est. completion 2028-06 1 site
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05916196

    [18F]FES PET/.CT in Uterine Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2028-08-01 1 site Stand-alone
    Other conditions: Uterine Cancer
    View official trial listing →
  • Recruiting NCT NCT05989347

    Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

    Not yet reported Yale University 20 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06006091

    The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET)

    Not yet reported International Peace Maternity and Child Health Hospital 858 participants Est. completion 2027-08-01 1 site
    Other conditions: Letrozole, Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT06101303

    Endometriosis Pain

    Washington University School of Medicine 120 participants Est. completion 2029-09-01 1 site
    Other conditions: Pelvic Pain, Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06107673

    Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

    Not yet reported Hebei Medical University Fourth Hospital 144 participants Est. completion 2028-12-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06280560

    Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation

    Fundación IVI 60 participants Est. completion 2026-12-30 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Recruiting NCT NCT06291675

    Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

    Medical University of Vienna 50 participants Est. completion 2033-03-03 1 site
    Other conditions: Gender Dysphoria, Hormone Therapy Induced Morphologic Change
    View official trial listing →
  • Recruiting NCT NCT06372119

    Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

    Not yet reported Mỹ Đức Hospital 790 participants Est. completion 2026-04 2 sites
    Other conditions: Embryo Transfer, Irregular Menstruation, Letrozole, Hormone Replacement Therapy
    View official trial listing →
  • Recruiting NCT NCT06439524

    The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial

    Not yet reported Main Line Health 110 participants Est. completion 2028-12-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06450301

    Senescent Endometrial Cells in Patients with Thin Endometrial Lining

    Trio Fertility 100 participants Est. completion 2027-06 1 site
    Other conditions: Asherman's Syndrome, Thin Endometrial Lining, Cell Senescence
    View official trial listing →
  • Recruiting NCT NCT06497894

    No More Sleepless Nights in Perimenopause

    Not yet reported Insel Gruppe AG, University Hospital Bern 54 participants Est. completion 2027-01-30 1 site
    Other conditions: Insomnia, Menopause
    View official trial listing →
  • Recruiting NCT NCT06570460

    Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

    Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT06679491

    Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes

    Not yet reported Universite de La Reunion 60 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Menstrual Cycle, Resistance Training, Neuromuscular Function, Female Athlete, Women Health, Oral Contraceptive Pill, Muscle Strenght, Hormones, Periodized Training
    View official trial listing →
  • Recruiting NCT NCT06734533

    Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .

    Hunan Cancer Hospital 80 participants Est. completion 2025-12-30 1 site
    Other conditions: HR+ Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06757634

    Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

    Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 203 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06758128

    Genetic and Immunity in Heart Failure

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 215 participants Est. completion 2026-09-30 2 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06807580

    Progesterone in Gender Affirming Hormone Therapy Study

    Not yet reported Emory University 40 participants Est. completion 2027-02 1 site
    Other conditions: Transgender Women
    View official trial listing →
  • Recruiting NCT NCT06852365

    Combined Oral Contraceptive Pill and Resistance Starch

    Not yet reported University of Pennsylvania 100 participants Est. completion 2028-04 1 site
    Metabolic syndrome Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06866119

    Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency

    Massachusetts General Hospital 45 participants Est. completion 2029-06-30 1 site
    Other conditions: Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications, Endothelial Function (FMD), Estrogen Replacement Therapy
    View official trial listing →
  • Recruiting NCT NCT06936930

    Reproductive and Mental Health of Patients With Aplastic Anemia

    Institute of Hematology & Blood Diseases Hospital, China 600 participants Est. completion 2027-12-31 1 site
    Other conditions: Aplastic Anemia, Reproductive Health
    View official trial listing →
  • Recruiting NCT NCT06964906

    Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2030-12-31 1 site
    Other conditions: ER+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06969326

    Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

    Not yet reported Women and Infants Hospital of Rhode Island 48 participants Est. completion 2026-12-01 1 site
    Other conditions: Postoperative Bleeding, Gender Dysphoria, Hysterectomy
    View official trial listing →
  • Recruiting NCT NCT06979596

    A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 59 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT07010146

    Role of Estrogen on Skeletal Outcomes in FHA

    Not yet reported University of Virginia 150 participants Est. completion 2030-05-31 2 sites
    Other conditions: Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)
    View official trial listing →
  • Recruiting NCT NCT07022340

    Hemodynamics After Resistance Training

    Not yet reported University of Michigan 50 participants Est. completion 2026-12 1 site
    Other conditions: Perimenopause
    View official trial listing →
  • Recruiting NCT NCT07037082

    Understanding Cycles to Improve Women's Health

    University Hospital, Montpellier 320 participants Est. completion 2029-07-01 1 site
    Other conditions: Woman of Reproductive Age, Socioeconomic Factors
    View official trial listing →
  • Recruiting NCT NCT07062965

    A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

    Not yet reported Pfizer 400 participants Est. completion 2030-11-04 202 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07109726

    A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    Not yet reported, Not yet reported Terremoto Biosciences Inc. 205 participants Est. completion 2029-02-28 18 sites
    Other conditions: Breast Cancer, Endometrial Cancer, Ovarian Cancer, Lung Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Solid Tumor, Cervical Cancer
    View official trial listing →
  • Recruiting NCT NCT07110883

    A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

    Not yet reported CSPC Megalith Biopharmaceutical Co.,Ltd. 400 participants Est. completion 2028-10-31 2 sites Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT07115082

    Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

    Not yet reported, Not yet reported Yan Hongli 50 participants Est. completion 2026-03-30 1 site
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Recruiting NCT NCT07180160

    Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer

    Not yet reported Wenjin Yin 123 participants Est. completion 2028-03 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07187947

    Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 500 participants Est. completion 2035-12-31 1 site
    Cardiovascular disease Other conditions: Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Health Status
    View official trial listing →
  • Recruiting NCT NCT07198724

    ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

    Not yet reported, Not yet reported Kristina A. Fanucci 65 participants Est. completion 2038-06-01 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer, HER2 Low Breast Carcinoma, HER2-negative Breast Cancer, Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Recruiting NCT NCT07347600

    A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

    Hoffmann-La Roche 500 participants Est. completion 2029-12-31 30 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07358468

    Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study

    Mỹ Đức Hospital 384 participants Est. completion 2027-12-01 2 sites
    Other conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis
    View official trial listing →
  • Recruiting NCT NCT07405801

    A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

    Not yet reported Hoffmann-La Roche 80 participants Est. completion 2030-02-26 58 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07421895

    A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

    The Third Xiangya Hospital of Central South University 600 participants Est. completion 2032-12-31 1 site
    Other conditions: Retained Products of Conception, RPOC
    View official trial listing →
  • Recruiting NCT NCT07427394

    Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 24 participants Est. completion 2027-12-28 6 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07616427

    Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2033-05-20 3 sites
    Other conditions: HR+/HER2+ Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07647328

    A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

    Not yet reported AstraZeneca 150 participants Est. completion 2029-02-28 89 sites
    Other conditions: ER-Positive HER2-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07675213

    Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles

    Mỹ Đức Hospital 442 participants Est. completion 2027-12-01 1 site
    Other conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis, Hormone Replacement Therapy (HRT)
    View official trial listing →
  • Recruiting NCT NCT07795736

    Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

    University of Calgary 200 participants Est. completion 2028-11-01 2 sites
    Other conditions: Growth Hormone Deficiency, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00000176

    Alzheimer's Disease Prevention Trial

    Not yet reported National Institute on Aging (NIA) Est. completion 2007-09 22 sites
    Other conditions: Alzheimer Disease, Memory Disorders
    View official trial listing →
  • Completed NCT NCT00001259

    A Treatment Study for Premenstrual Syndrome (PMS)

    Not yet reported National Institute of Mental Health (NIMH) 60 participants Est. completion 2020-02-06 1 site
    Other conditions: Premenstrual Syndrome, Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT00001275

    Ovarian Follicle Function in Patients With Primary Ovarian Failure

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1134 participants Est. completion 2017-02-08 1 site
    Other conditions: Amenorrhea, Hypoaldosteronism, Hypogonadism, Infertility, Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT00001454

    Hormonal Effects on the Uterus and Endometrium

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 129 participants Est. completion 2015-07-27 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT00001770

    Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)

    National Institute of Mental Health (NIMH) 50 participants Est. completion 2003-03 1 site
    Other conditions: Depressive Disorder, Mood Disorder, Psychomotor Agitation
    View official trial listing →
  • Completed NCT NCT00002721

    Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported University of New Mexico 18 participants Est. completion 2013-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00002775

    Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported, Not yet reported Herbert Irving Comprehensive Cancer Center 37 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002855

    Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 306 participants Est. completion 2005-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00003717

    Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported St. Barnabas Medical Center 17 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004274

    Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 260 participants 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00005011

    Combined Hormone Replacement in Menstrually-Related Mood Disorders

    National Institute of Mental Health (NIMH) 22 participants Est. completion 2016-10-28 1 site
    Other conditions: Premenstrual Syndrome, Depression
    View official trial listing →
  • Completed NCT NCT00005108

    Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-01 1 site
    Other conditions: Atherosclerosis, Healthy, Vascular Disease
    View official trial listing →
  • Status unknown NCT NCT00005923

    The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity

    National Center for Research Resources (NCRR) 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00006133

    Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

    Not yet reported National Center for Research Resources (NCRR) 970 participants 17 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00006399

    Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease

    Not yet reported National Center for Research Resources (NCRR) 45 participants Est. completion 2004-03 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00018343

    Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

    Not yet reported US Department of Veterans Affairs Est. completion 2001-03 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00027859

    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Eastern Cooperative Oncology Group 98 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00030095

    2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 2 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00043069

    Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 71 participants Est. completion 2010-01 114 sites Stand-alone
    Other conditions: Osteoporosis, Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00044837

    Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 120 participants 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00044876

    Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 56 participants Est. completion 2015-10-01 1 site
    Other conditions: Leiomyoma
    View official trial listing →
  • Completed NCT NCT00056082

    Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

    Not yet reported University of Kansas Medical Center 110 participants Est. completion 2013-07 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00057941

    Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 148 participants Est. completion 2012-06 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00066157

    Alzheimer's Disease: Therapeutic Potential of Estrogen

    Not yet reported, Not yet reported University of Wisconsin, Madison 42 participants Est. completion 2007-12 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00068328

    Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

    Alliance for Clinical Trials in Oncology 1706 participants Est. completion 2016-12 85 sites
    Other conditions: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00093002

    Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

    Not yet reported AstraZeneca 179 participants Est. completion 2007-07 31 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00137371

    Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 480 participants Est. completion 2007-09 49 sites
    Other conditions: Atrophic Vaginitis, Atrophy, Vaginitis
    View official trial listing →
  • Status unknown NCT NCT00150163

    Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men

    Odense University Hospital 800 participants Est. completion 2008-12 1 site
    Other conditions: Bone Diseases
    View official trial listing →
  • Completed NCT NCT00151073

    Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

    Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2007-09 1 site
    Other conditions: Hormone-Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00151086

    Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 33 participants Est. completion 2006-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00152282

    A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women

    Not yet reported Abbott 105 participants Est. completion 2001-08
    Other conditions: Amenorrhea, Postmenopause
    View official trial listing →
  • Status unknown NCT NCT00154180

    Kronos Early Estrogen Prevention Study (KEEPS)

    Not yet reported Kronos Longevity Research Institute 728 participants Est. completion 2012-07 9 sites
    Other conditions: Menopause, Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00160173

    Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

    Not yet reported ASCEND Therapeutics 221 participants Est. completion 2005-09-06 109 sites
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00160316

    Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

    Not yet reported Solvay Pharmaceuticals 454 participants Est. completion 2007-12 22 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00163033

    Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women

    Not yet reported Pantarhei Bioscience 49 participants Est. completion 2007-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00185328

    Efficacy and Tolerability of Angeliq in Thai Women

    Not yet reported Bayer 55 participants Est. completion 2006-12
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00193271

    Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

    Not yet reported SCRI Development Innovations, LLC 30 participants Est. completion 2007-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00196378

    A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

    Not yet reported Duramed Research 300 participants Est. completion 2006-02 38 sites
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT00203996

    Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

    Not yet reported University of Chicago 37 participants Est. completion 2008-06 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00204451

    Human Ovarian Follicular Dynamics and Emergency Contraception

    Not yet reported University of Saskatchewan 40 participants Est. completion 2006-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00206544

    Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

    Not yet reported The Alfred 51 participants Est. completion 2007-12 1 site
    Other conditions: Bipolar Disorder, Mania, Schizoaffective Disorder
    View official trial listing →
  • Status unknown NCT NCT00218205

    A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

    Not yet reported Department of Veterans Affairs, New Jersey 28 participants Est. completion 2006-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00230815

    A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

    Not yet reported EMD Serono 62 participants Est. completion 2005-11
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00234676

    POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

    Not yet reported The Parkinson Study Group 23 participants Est. completion 2006-03 6 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00240071

    Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

    Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00241449

    A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sites
    Other conditions: Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT00244998

    Fulvestrant in Treating Patients With Advanced Prostate Cancer

    Not yet reported Roswell Park Cancer Institute 20 participants Est. completion 2012-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00245921

    Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 2000 participants Est. completion 2005-10
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00253539

    Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

    Not yet reported The Cleveland Clinic 3 participants Est. completion 2005-04
    Other conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2)
    View official trial listing →
  • Completed NCT NCT00255125

    Role of Soy Supplementation in Prostate Cancer Development

    Not yet reported VA Office of Research and Development 86 participants Est. completion 2009-10 1 site
    Other conditions: Prostate Neoplasm
    View official trial listing →
  • Completed NCT NCT00263341

    Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol

    Not yet reported Population Council 1135 participants Est. completion 2014-08 12 sites
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00267553

    Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 200 participants Est. completion 2006-06 35 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Completed NCT NCT00269620

    PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra

    Not yet reported University of Pittsburgh 500 participants Est. completion 2006-12 10 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00294463

    Effects of Tibolone Treatment on the Endometrium

    Not yet reported Erasmus Medical Center 35 participants Est. completion 2005-03 1 site
    Other conditions: Postmenopause, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00305825

    Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

    Not yet reported University of California, San Francisco 43 participants Est. completion 2016-05-24 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00319566

    Heart and Estrogen-Progestin Replacement Study (HERS)

    Not yet reported University of California, San Francisco 2430 participants Est. completion 2001-07 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00320580

    An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 239 participants Est. completion 2003-03
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00322348

    Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

    Not yet reported AstraZeneca 98 participants Est. completion 2009-11 14 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00328120

    Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

    Not yet reported AstraZeneca 20 participants Est. completion 2010-06 5 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00328497

    A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

    Not yet reported CASI pharmaceuticals, Inc. 31 participants Est. completion 2009-12 1 site
    Other conditions: Carcinoid Tumor
    View official trial listing →
  • Terminated NCT NCT00328926

    Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

    Not yet reported EMD Serono 11 participants Est. completion 2012-05 1 site
    Other conditions: Hypogonadotropic Hypogonadism
    View official trial listing →
  • Completed NCT NCT00356447

    Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

    Not yet reported Bayer 249 participants Est. completion 2007-10 9 sites
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00357006

    A Definitive Estrogen Patch Study (ADEPT)

    Not yet reported The Alfred 180 participants Est. completion 2013-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)
    View official trial listing →
  • Terminated NCT NCT00358098

    Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

    AHS Cancer Control Alberta 51 participants Est. completion 2013-06 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00361075

    Midlife Cholesterol Study

    Not yet reported Northwestern University 120 participants Est. completion 2005-05 2 sites
    Cardiovascular disease Other conditions: Menopause, Postmenopause, Premenopause
    View official trial listing →
  • Completed NCT NCT00393172

    Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]

    Not yet reported, Not yet reported University of Minnesota 400 participants Est. completion 2010-03 1 site
    Other conditions: Breast Cancer, Obesity
    View official trial listing →
  • Completed NCT NCT00417430

    Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies

    Not yet reported The Center for Rheumatic Disease, Allergy, & Immunology 20 participants Est. completion 2006-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00423917

    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2017-01-15 205 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00435175

    Acute Metabolic Effects of Estradiol

    Not yet reported University of Aarhus 8 participants Est. completion 2006-07 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Withdrawn NCT NCT00447863

    Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-08
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00451555

    Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

    Not yet reported Eli Lilly and Company 156 participants Est. completion 2018-10-18 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00463450

    Efficacy of Gynodian® Depot in Women With Impaired Well-being

    Not yet reported Bayer 140 participants Est. completion 2004-04
    Other conditions: Hormone Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00463489

    Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer

    Not yet reported Ontario Clinical Oncology Group (OCOG) 338 participants Est. completion 2018-06 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00463788

    Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

    Not yet reported Merck KGaA, Darmstadt, Germany 181 participants Est. completion 2011-02 46 sites
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT00464789

    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-05
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00475553

    Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

    Not yet reported Scott and White Hospital & Clinic 75 participants Est. completion 2008-05 1 site
    Other conditions: Breakthrough Bleeding, Breakthrough Spotting
    View official trial listing →
  • Status unknown NCT NCT00490308

    The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment

    Not yet reported Assaf-Harofeh Medical Center 120 participants Est. completion 2008-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT00503841

    Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute 44 participants Est. completion 2010-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00505752

    Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

    Not yet reported Merck KGaA, Darmstadt, Germany 520 participants Est. completion 2008-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT00506480

    Assessment of Endometrial Receptivity in Recipients of Donated Oocytes

    Not yet reported Hadassah Medical Organization 100 participants Stand-alone
    Other conditions: Embryo Implantation
    View official trial listing →
  • Completed NCT NCT00511342

    Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)

    Not yet reported Organon and Co 110 participants Est. completion 2009-06
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00517556

    Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea

    Not yet reported, Not yet reported Milton S. Hershey Medical Center 38 participants Est. completion 2011-04 1 site
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Status unknown NCT NCT00519454

    Estrogen and Gender Biased Autoimmunity

    The Center for Rheumatic Disease, Allergy, & Immunology 75 participants Est. completion 2013-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00534417

    Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Accelerated Community Oncology Research Network 41 participants Est. completion 2011-09 10 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00541281

    Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150 participants Est. completion 2006-02 19 sites
    Other conditions: Hormone Resistant Prostate Cancer, Metastatic Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00551733

    Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

    Not yet reported CTI BioPharma 450 participants Est. completion 2007-12-25 41 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00563472

    Feasibility Study Into the Contraceptive Effect of Estetrol

    Not yet reported Pantarhei Bioscience 52 participants Est. completion 2008-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00572390

    Oestrogen Withdrawal in Hypopituitary Women

    Not yet reported University of Aarhus 38 participants Est. completion 2002-02 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Active, not recruiting NCT NCT00587886

    Estrogen, Diet, Genetics and Endometrial Cancer

    Memorial Sloan Kettering Cancer Center 1315 participants Est. completion 2026-12-31 1 site
    Other conditions: Cancer, Endometrial Cancer, Ovarian Cancer, Corpus Uteri, Endometrium
    View official trial listing →
  • Completed NCT NCT00589134

    The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration

    Not yet reported Yale University 26 participants Est. completion 2009-12 1 site
    Other conditions: Exercise Induced Hyponatremia
    View official trial listing →
  • Completed NCT NCT00592579

    A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma

    Not yet reported CASI pharmaceuticals, Inc. 60 participants Est. completion 2008-09 2 sites
    Other conditions: Relapsed Multiple Myeloma, Plateau Phase Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00608062

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    Not yet reported University of Colorado, Denver 155 participants Est. completion 2012-10-25 1 site
    Other conditions: Arterial Stiffening, Aging, Menopause
    View official trial listing →
  • Completed NCT NCT00612508

    Hormonal Contraception and Vaginal Health

    Not yet reported Oregon Health and Science University 14 participants Est. completion 2008-05 1 site
    Other conditions: Contraceptive Usage, Vaginal Epithelial Disruption
    View official trial listing →
  • Completed NCT NCT00653614

    Cycle Control and Safety of E2-DRSP

    Not yet reported Bayer 635 participants Est. completion 2009-06 25 sites
    Other conditions: Contraceptive, Oral, Hormonal
    View official trial listing →
  • Completed NCT NCT00676663

    Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

    Not yet reported Syndax Pharmaceuticals 130 participants Est. completion 2012-11-26 38 sites
    Other conditions: Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00684216

    Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

    Not yet reported, Not yet reported The Netherlands Cancer Institute 10 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00699751

    A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

    Not yet reported Bayer 921 participants Est. completion 2014-02-13 134 sites
    Other conditions: Hormone Refractory Prostate Cancer, Bone Metastases
    View official trial listing →
  • Completed NCT NCT00702520

    Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)

    Organon and Co 15 participants Est. completion 2008-01-15
    Other conditions: Pregnancy, Neonates
    View official trial listing →
  • Completed NCT NCT00722761

    Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2012-04 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT00745173

    Study Evaluating Premarin and Bazedoxifene Potential Interaction

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-10 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00752635

    Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

    Not yet reported Johnson & Johnson Taiwan Ltd 48 participants Est. completion 2005-09
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT00781456

    A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

    Not yet reported Duramed Research 109 participants Est. completion 2011-08 22 sites
    Other conditions: Migraine
    View official trial listing →
  • Status unknown NCT NCT00789022

    Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment

    Shalvata Mental Health Center 80 participants 1 site
    Other conditions: Schizophrenia, Schizophreniform, Schizoaffective Disorder, Brief Psychotic Episode
    View official trial listing →
  • Completed NCT NCT00789802

    A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC

    Not yet reported Washington University School of Medicine 129 participants Est. completion 2011-01 1 site
    Other conditions: Contraception, Bleeding
    View official trial listing →
  • Completed NCT NCT00803335

    The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse

    Not yet reported TriHealth Inc. 54 participants Est. completion 2011-05 1 site
    Other conditions: Pelvic Organ Prolapse, Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00805415

    Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

    Not yet reported Bayer 209 participants Est. completion 2004-02 2 sites Stand-alone
    Other conditions: Ovulation Inhibition
    View official trial listing →
  • Withdrawn NCT NCT00827151

    Bone Mass Accrual in Adolescent Athletes

    Not yet reported Massachusetts General Hospital Est. completion 2015-01 1 site
    Other conditions: Amenorrhea, Bone Loss
    View official trial listing →
  • Completed NCT NCT00830973

    The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

    Medco Health Solutions, Inc. 184 participants Est. completion 2009-01 1 site
    Other conditions: Breast Neoplasms, Tamoxifen
    View official trial listing →
  • Completed NCT NCT00839696

    Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

    University of Wisconsin, Madison 270 participants Est. completion 2010-04 1 site
    Other conditions: Breast Cancer Risk
    View official trial listing →
  • Completed NCT NCT00856492

    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

    Not yet reported SWOG Cancer Research Network 215 participants Est. completion 2015-12 366 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00892268

    Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain

    Not yet reported University of Arizona 68 participants Est. completion 2009-10
    Other conditions: Breast Cancer, Menopausal Symptoms, Pain
    View official trial listing →
  • Completed NCT NCT00897208

    Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

    Mayo Clinic 316 participants Est. completion 2015-06-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00898976

    Biomarkers in Native American Women With Breast Cancer

    Alliance for Clinical Trials in Oncology 120 participants Est. completion 2007-05
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00900653

    Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women

    Not yet reported Yonsei University 142 participants Est. completion 2010-07 1 site
    Other conditions: Urinary Tract Infections
    View official trial listing →
  • Suspended NCT NCT00901290

    Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

    Not yet reported AstraZeneca 56 participants Est. completion 2009-09 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00905684

    Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

    Bayer 5446 participants Est. completion 2011-12 13 sites
    Other conditions: Contraception
    View official trial listing →
  • Withdrawn NCT NCT00915668

    A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2011-03
    Other conditions: Pharmacokinetics, Drug Interactions, Healthy
    View official trial listing →
  • Completed NCT NCT00915915

    Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)

    Not yet reported Bayer 108 participants Est. completion 2010-04 2 sites
    Other conditions: Contraception, Ovulation Inhibition
    View official trial listing →
  • Status unknown NCT NCT00919919

    Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

    Not yet reported Rabin Medical Center 60 participants Est. completion 2010-11 1 site
    Other conditions: Endometrial Hyperplasia, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00921115

    Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

    Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 site
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT00923572

    Yasmin Post Marketing Surveillance

    Bayer 777 participants Est. completion 2013-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00933179

    FC Patch Low: Metabolism Study

    Not yet reported Bayer 30 participants Est. completion 2010-09 1 site
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT00954135

    Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

    Not yet reported University of Turin, Italy 190 participants Est. completion 2010-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00956813

    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 210 participants Est. completion 2013-05 107 sites
    Other conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00963417

    Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

    Not yet reported ETOP IBCSG Partners Foundation 119 participants Est. completion 2024-10-23 13 sites
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00988910

    Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

    Bayer 632 participants Est. completion 2010-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Withdrawn NCT NCT00999479

    Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation

    Not yet reported University of Oklahoma Est. completion 2011-10 1 site Stand-alone
    Other conditions: Endometrioma
    View official trial listing →
  • Completed NCT NCT01007071

    Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency

    Not yet reported Stanford University 11 participants Est. completion 2012-12-12 1 site Stand-alone
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT01009437

    Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 28 participants Est. completion 2014-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01047358

    Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

    Pfizer 206 participants Est. completion 2014-06 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01056042

    Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain

    Not yet reported Prince of Songkla University 112 participants Est. completion 2011-10 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT01065220

    Sex Steroids and the Serotonin Transporter

    Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Terminated NCT NCT01083641

    Estrogen for Triple Negative Breast Cancer

    Not yet reported University of Wisconsin, Madison 17 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT01087879

    The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism

    Not yet reported University of Oulu 45 participants Est. completion 2011-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01088477

    Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer

    University Medical Center Groningen 21 participants Est. completion 2014-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01129830

    The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

    Not yet reported Virginia Center for Reproductive Medicine 200 participants Est. completion 2014-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01142401

    Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2021-01-08 21 sites
    Other conditions: Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01147484

    A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer

    Not yet reported NCIC Clinical Trials Group 47 participants Est. completion 2015-02-13 9 sites
    Other conditions: Recurrent Breast Cancer
    View official trial listing →
  • Completed NCT NCT01157182

    Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2007-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01185704

    Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

    Not yet reported Merck KGaA, Darmstadt, Germany 136 participants Est. completion 2012-02 1 site
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT01197170

    Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

    Not yet reported M.D. Anderson Cancer Center 277 participants Est. completion 2021-01-13 1 site
    Other conditions: Solid Tumors, Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01216176

    A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

    Not yet reported, Not yet reported Joyce Marie Slingerland, MD 71 participants Est. completion 2018-02-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01219153

    Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET

    Not yet reported Cairo University 136 participants Est. completion 2010-12 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01230970

    Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

    Not yet reported Ipsen 2 participants Est. completion 2011-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01239888

    Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study

    Not yet reported The Alfred 15 participants 1 site
    Other conditions: Depression, Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT01246791

    Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

    Not yet reported Nobelpharma 12 participants Est. completion 2011-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01250314

    Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density

    Not yet reported Assistance Publique - Hôpitaux de Paris 79 participants Est. completion 2010-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT01251354

    Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

    Not yet reported Ipsen 6 participants Est. completion 2011-07 9 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT01253187

    Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

    Not yet reported Bayer 44 participants Est. completion 2007-09 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01268046

    Aging and Estrogen on Cortical Function

    Not yet reported, Not yet reported Massachusetts General Hospital 38 participants Est. completion 2013-12-02 1 site Stand-alone
    Other conditions: Memory Loss, Cognitive Changes, Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT01281137

    Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07

    ETOP IBCSG Partners Foundation 104 participants Est. completion 2019-05-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01282164

    The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

    Not yet reported The Cleveland Clinic 43 participants Est. completion 2014-07 4 sites
    Other conditions: Adult Growth Hormone Deficiency, Hypothalamic-pituitary Disorders
    View official trial listing →
  • Completed NCT NCT01295892

    Chronic Effects of Estrogen in Microcirculation

    Not yet reported Rio de Janeiro State University 44 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT01311037

    The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

    King Faisal Specialist Hospital & Research Center 2 participants 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT01313039

    Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer

    Not yet reported University of Miami 4 participants Est. completion 2014-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01319968

    Postpartum Dyspareunia Resulting From Vaginal Atrophy

    Meir Medical Center 117 participants Est. completion 2013-09 2 sites
    Other conditions: Vulvovaginal Atrophy, Dyspareunia Among Puerperal Women
    View official trial listing →
  • Active, not recruiting NCT NCT01327781

    Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2026-10-30 3 sites
    Other conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01329562

    CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet

    Not yet reported Cady, Roger, M.D. 41 participants Est. completion 2012-06 2 sites
    Other conditions: Menstrual Migraine
    View official trial listing →
  • Completed NCT NCT01344369

    Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

    Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2008-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01373931

    A Study of LY2216684 in Healthy Females

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2011-12 1 site
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Status unknown NCT NCT01384331

    New Treatments for Troublesome Bleeding in Implanon Users

    Not yet reported Family Planning Association New South Wales 200 participants Est. completion 2013-04 1 site
    Other conditions: Menstrual Problem
    View official trial listing →
  • Completed NCT NCT01418209

    MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms

    Not yet reported Fred Hutchinson Cancer Center 339 participants Est. completion 2013-01 4 sites
    Other conditions: Hot Flashes, Menopause, Vasomotor Disturbance
    View official trial listing →
  • Status unknown NCT NCT01420185

    Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

    NSABP Foundation Inc 1300 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01425541

    Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition

    Not yet reported University of Virginia 60 participants Est. completion 2025-08 1 site Stand-alone
    Other conditions: Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS)
    View official trial listing →
  • Completed NCT NCT01441947

    Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

    Not yet reported Massachusetts General Hospital 68 participants Est. completion 2019-08-09 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01471106

    Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 26 participants Est. completion 2024-05-30 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01471457

    Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis

    Not yet reported, Not yet reported University of New Mexico 184 participants Est. completion 2014-09 2 sites
    Other conditions: Bacterial Vaginosis
    View official trial listing →
  • Completed NCT NCT01500863

    Endometrial Receptivity After GnRH Agonist Triggering

    Not yet reported IVI Madrid 35 participants 1 site Stand-alone
    Other conditions: Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT01511822

    Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

    Not yet reported AGUNCO Obstetrics and Gynecology Centre 1 site
    Other conditions: PCOS, Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01535820

    The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2011-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01569113

    Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

    Not yet reported HRA Pharma 76 participants Est. completion 2012-08 3 sites
    Other conditions: Emergency Contraception
    View official trial listing →
  • Completed NCT NCT01569945

    Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur

    Not yet reported University Hospital, Gasthuisberg 371 participants Est. completion 2011-12 1 site
    Other conditions: Subfertility
    View official trial listing →
  • Status unknown NCT NCT01590849

    Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone

    Not yet reported Instituto do Coracao 69 participants 1 site
    Other conditions: Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood Pressure
    View official trial listing →
  • Completed NCT NCT01602380

    A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

    Not yet reported AstraZeneca 462 participants Est. completion 2026-01-16 118 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01602770

    Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy

    Bayer 1 participants Est. completion 2017-10-31 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01615354

    A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers

    Not yet reported Hoffmann-La Roche 18 participants Est. completion 2013-01 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01626222

    4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 301 participants Est. completion 2013-11 84 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01633060

    A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

    Not yet reported Novartis Pharmaceuticals 432 participants Est. completion 2017-09-21 197 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01633528

    The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy

    Not yet reported Royan Institute 60 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01638910

    Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

    Not yet reported Bayer 955 participants Est. completion 2014-11 39 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01638923

    Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

    Not yet reported Bayer 339 participants Est. completion 2015-06 41 sites Stand-alone
    Other conditions: Metrorrhagia
    View official trial listing →
  • Terminated NCT NCT01648751

    Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse

    Not yet reported Pamela Moalli 21 participants Est. completion 2023-03-02 1 site Stand-alone
    Other conditions: Pelvic Organ Prolapse
    View official trial listing →
  • Completed NCT NCT01650168

    Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

    Center for Epidemiology and Health Research, Germany 101498 participants Est. completion 2020-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01654185

    Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

    Not yet reported Xichun Hu 60 participants Est. completion 2016-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01654367

    Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

    Not yet reported, Not yet reported Tianjin Medical University 300 participants Est. completion 2013-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01655225

    A Study of LY3023414 in Participants With Advanced Cancer

    Not yet reported Eli Lilly and Company 156 participants Est. completion 2022-02-02 8 sites
    Other conditions: Advanced Cancer, Metastatic Cancer, Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Malignant Mesothelioma, Non-small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT01656434

    Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

    Not yet reported Organon and Co 3173 participants Est. completion 2014-02-12
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01668446

    Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles

    Not yet reported farzaneh hojjat 2 participants Est. completion 2011-02 1 site
    Other conditions: Endometrial Preparation, Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT01694225

    Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

    Not yet reported University of Louisville 87 participants Est. completion 2018-01-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01714128

    FES-PET for Patients Treated on NCI Protocol 8762

    Not yet reported Washington University School of Medicine Est. completion 2015-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01822288

    The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

    Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 site
    Other conditions: Menopausal Syndromes
    View official trial listing →
  • Terminated NCT NCT01856036

    Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers

    Not yet reported Saint John's Cancer Institute 2 participants Est. completion 2014-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01874756

    The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia

    Not yet reported Indiana University 95 participants Est. completion 2017-12 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01899079

    A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay

    NanoString Technologies, Inc. 217 participants Est. completion 2014-07 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01902264

    Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception

    Not yet reported Bayer 34 participants Est. completion 2015-02 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01903031

    Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84 participants Est. completion 2016-10-10 21 sites
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Terminated NCT NCT01918306

    GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer

    Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 11 participants Est. completion 2015-04 16 sites
    Other conditions: Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01924078

    Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer

    Not yet reported Fudan University 100 participants Est. completion 2015-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01933204

    Acupuncture for Relieving Perimenopausal Symptoms

    Not yet reported, Not yet reported Chengdu University of Traditional Chinese Medicine 220 participants Est. completion 2015-08 2 sites
    Other conditions: Perimenopause
    View official trial listing →
  • Completed NCT NCT01942759

    The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer

    Bagcilar Training and Research Hospital 43 participants Est. completion 2014-06 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01953211

    Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity

    University of Southern California 64 participants 1 site
    Other conditions: Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy
    View official trial listing →
  • Withdrawn NCT NCT01953809

    A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

    Not yet reported GlaxoSmithKline Est. completion 2015-03
    Other conditions: Infections, Bacterial
    View official trial listing →
  • Terminated NCT NCT01963403

    Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive

    Not yet reported University of California, Davis 26 participants Est. completion 2015-09 2 sites
    Other conditions: Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding Heavy
    View official trial listing →
  • Completed NCT NCT01980680

    The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

    Not yet reported Peter Humaidan 50 participants Est. completion 2020-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01999569

    The Role of Estrogen in Luteinizing Hormone Surge and Ovulation

    Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2008-05 1 site
    Other conditions: Ovulation Disorder, Ovarian Cysts
    View official trial listing →
  • Status unknown NCT NCT02000193

    Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

    Not yet reported Sun Yat-sen University 58 participants Est. completion 2018-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02021097

    Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

    Not yet reported Regenex Pharmaceutical, China 1008 participants Est. completion 2016-02 21 sites
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT02033512

    TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS

    Not yet reported University Potiguar 66 participants Est. completion 2008-04 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02042196

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    Not yet reported University of Colorado, Denver 100 participants Est. completion 2016-05-02 1 site Stand-alone
    Other conditions: Menopause, Aging
    View official trial listing →
  • Completed NCT NCT02057536

    The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.

    Not yet reported Christiana Care Health Services 30 participants Est. completion 2015-03 1 site
    Other conditions: Women With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and Stiffness
    View official trial listing →
  • Status unknown NCT NCT02072512

    The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer

    Not yet reported Hospital Affiliated to Military Medical Science, Beijing 180 participants Est. completion 2016-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02088684

    Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 70 participants Est. completion 2018-04-17 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02118636

    Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms

    Lynn Henry 75 participants Est. completion 2015-09 1 site
    Other conditions: Breast Cancer, Arthralgia
    View official trial listing →
  • Completed NCT NCT02137083

    A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

    Not yet reported Fudan University 22 participants Est. completion 2017-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02158572

    Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

    Not yet reported Agile Therapeutics 2032 participants Est. completion 2016-11
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02159131

    Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

    Not yet reported ViiV Healthcare 20 participants Est. completion 2014-12 1 site
    Other conditions: Infections, Human Immunodeficiency Virus and Hepatitis
    View official trial listing →
  • Completed NCT NCT02161614

    Vascular Effect of Estradiol Valerate Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

    Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Flow-mediated Dilation Evaluation of the Brachial Artery
    View official trial listing →
  • Completed NCT NCT02182791

    Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women

    Not yet reported Boehringer Ingelheim 14 participants
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT02195986

    A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

    Not yet reported Mylan Pharmaceuticals Inc 366 participants Est. completion 2014-12 21 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Completed NCT NCT02263846

    Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer

    Affiliated Hospital to Academy of Military Medical Sciences 1183 participants Est. completion 2013-07
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02269670

    Phase II Study of Everolimus Beyond Progression

    Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT02316509

    A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

    Not yet reported Genentech, Inc. 43 participants Est. completion 2020-01-10 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02352090

    Synthetic vs Natural Estrogen in Combined Oral Contraception

    Not yet reported Helsinki University Central Hospital 59 participants Est. completion 2018-12-30 2 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02352597

    Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS

    Not yet reported Cairo University 150 participants Est. completion 2015-01
    Other conditions: Polycystic Ovaries
    View official trial listing →
  • Status unknown NCT NCT02383030

    Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

    Not yet reported Consorzio Oncotech 156 participants Est. completion 2017-12 20 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02385448

    Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery

    Not yet reported The University of Hong Kong 144 participants Est. completion 2019-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02434562

    Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

    Universitaire Ziekenhuizen KU Leuven 73 participants Est. completion 2016-09-30
    Other conditions: Hypogonadism, Estrogens, Testosterone, Androgens
    View official trial listing →
  • Status unknown NCT NCT02467686

    Breast Cancer, Sexuality and Black Cohosh

    Not yet reported Irmandade da Santa Casa de Misericordia de Sao Paulo 60 participants Est. completion 2017-12 1 site
    Other conditions: Sexuality
    View official trial listing →
  • Completed NCT NCT02475265

    Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

    Not yet reported Massachusetts General Hospital 11 participants Est. completion 2018-07-30 1 site
    Obstructive sleep apnea Other conditions: Osteoporosis
    View official trial listing →
  • No Longer Available NCT NCT02480777

    Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair

    W. Dalton Dietrich 1 site
    Other conditions: Sciatic Nerve Injury
    View official trial listing →
  • Completed NCT NCT02516202

    The Vaginal Health Trial

    Not yet reported Fred Hutchinson Cancer Center 302 participants Est. completion 2017-07 2 sites
    Other conditions: Atrophy of Vagina, Menopause, Dyspareunia (Female)
    View official trial listing →
  • Terminated NCT NCT02540330

    A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant

    Not yet reported Atossa Therapeutics, Inc. 3 participants Est. completion 2020-08-13 3 sites
    Other conditions: Female Breast Carcinoma, Female Ductal Carcinoma In Situ
    View official trial listing →
  • Terminated NCT NCT02577913

    European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception

    Center for Epidemiology and Health Research, Germany 2281 participants Est. completion 2019-05-22 1 site
    Other conditions: Contraception
    View official trial listing →
  • Suspended NCT NCT02599077

    Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas

    Not yet reported, Not yet reported Fundación Santa Fe de Bogota 50 participants Est. completion 2018-11 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02599714

    Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

    Not yet reported AstraZeneca 54 participants Est. completion 2023-11-23 7 sites
    Other conditions: Advanced and Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02613039

    Oral Contraceptive Therapy and Sexuality

    Not yet reported University of Florence 10 participants Est. completion 2019-02 1 site
    Other conditions: Contraceptive Usage, Sexual Behavior, Mental Health Wellness 1
    View official trial listing →
  • Terminated NCT NCT02616146

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)

    Not yet reported Organon and Co 2016 participants Est. completion 2016-10-06 14 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02620124

    GnRH Agonist as Luteal Support in FET Cycles

    Not yet reported Turku University Hospital 100 participants Est. completion 2015-10 Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02626208

    Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone

    Not yet reported Premier Research 65 participants Est. completion 2017-03 7 sites
    Other conditions: Suppression of Ovulation
    View official trial listing →
  • Completed NCT NCT02636972

    The Progression From Dysmenorrhoea to Chronic Pelvic Pain

    University of Adelaide 56 participants Est. completion 2016-01 1 site
    Other conditions: Dysmenorrhoea, Pelvic Pain, Chronic Pain
    View official trial listing →
  • Status unknown NCT NCT02638922

    Evaluation and Treatment of Tall Statured Girls

    Rigshospitalet, Denmark 304 participants Est. completion 2017-12
    Other conditions: Constitutional Tall Stature
    View official trial listing →
  • Completed NCT NCT02640755

    Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

    Not yet reported AstraZeneca 4 participants Est. completion 2017-07-06 1 site
    Other conditions: Solid Malignancies
    View official trial listing →
  • Completed NCT NCT02640976

    Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

    Not yet reported Cairo University 216 participants Est. completion 2015-08
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02655146

    the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .

    Not yet reported Chong Qing Reproducive and Genetic Institute 700 participants Est. completion 2017-03 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT02668783

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)

    Not yet reported Organon and Co 25 participants Est. completion 2016-09-07
    Other conditions: Moderate to Severe Primary Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT02668822

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)

    Not yet reported Organon and Co 18 participants Est. completion 2016-09-12
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT02675231

    A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

    Not yet reported Eli Lilly and Company 237 participants Est. completion 2023-11-09 93 sites
    Other conditions: Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02692755

    Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer

    Not yet reported, Not yet reported Georgetown University 35 participants Est. completion 2021-03-23 6 sites
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02701452

    Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response

    Not yet reported University Hospital, Lille 1 participants Est. completion 2019-01-01
    Other conditions: Ovarian Hyperstimulation Syndrome, Hypercoagulability
    View official trial listing →
  • Status unknown NCT NCT02715232

    Effects of Sex Steroids on the Serotonin System

    Not yet reported Medical University of Vienna 92 participants Est. completion 2020-12 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT02718144

    Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer

    Not yet reported, Not yet reported Pantarhei Oncology B.V. 12 participants Est. completion 2019-12-31 2 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02736032

    Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

    Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT02751385

    Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

    Not yet reported Boehringer Ingelheim 2 participants Est. completion 2017-11-28 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Status unknown NCT NCT02757469

    Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

    Not yet reported Navy General Hospital, Beijing 20 participants Est. completion 2021-05 1 site
    Other conditions: Primary Ovarian Insufficiency, Menopause, Premature
    View official trial listing →
  • Completed NCT NCT02760030

    Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

    Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sites
    Other conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02761694

    Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)

    Not yet reported ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 78 participants Est. completion 2021-03-10 6 sites
    Other conditions: Cancer, Solid Tumors
    View official trial listing →
  • Completed NCT NCT02832180

    The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects

    Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2016-10 2 sites
    Other conditions: Arthritis
    View official trial listing →
  • Completed NCT NCT02834312

    E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

    Not yet reported Donesta Bioscience 260 participants Est. completion 2018-01-22 1 site
    Other conditions: Hot Flushes
    View official trial listing →
  • Completed NCT NCT02871791

    Palbociclib With Everolimus + Exemestane In BC

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 41 participants Est. completion 2021-09 1 site
    Other conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor (HR)-Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02894398

    Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant

    Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Status unknown NCT NCT02915380

    Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage

    Dr. Rita Bertuetti 50 participants Est. completion 2018-01
    Other conditions: Thyroid Disfunction, Subarachnoid Haemorrhage From Cerebral Aneurism Rupture, Pituitary Disfunction
    View official trial listing →
  • Withdrawn NCT NCT02922348

    Hormone Replacement for Premature Ovarian Insufficiency

    Not yet reported University of Pennsylvania Est. completion 2018-12-01 1 site
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Completed NCT NCT02951949

    Estrogen Exposure and Atherosclerosis in Postmenopausal Women

    University of Valencia 92 participants Est. completion 2015-12 1 site
    Other conditions: Atherosclerosis, Menopause, Estrogens, Carotid Intima-media Thickness, Coronary Stenoses, Women
    View official trial listing →
  • Active, not recruiting NCT NCT02955394

    Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

    Not yet reported University of Colorado, Denver 61 participants Est. completion 2027-02 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02957630

    "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

    Not yet reported, Not yet reported Estetra 101 participants Est. completion 2017-10-09 1 site
    Other conditions: Contraception, Liver Metabolism, Hemostasis Parameter
    View official trial listing →
  • Withdrawn NCT NCT03005275

    A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women

    Not yet reported Vietnam National University Est. completion 2017-04
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03018366

    Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

    Not yet reported Cedars-Sinai Medical Center 29 participants Est. completion 2023-02-01 1 site
    Cardiovascular disease Other conditions: Estrogen Deficiency, Functional Hypothalamic Amenorrhea, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT03043924

    Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)

    Not yet reported University Hospital, Lille 52 participants Est. completion 2022-04-15 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT03074045

    LCS16 vs. COC User Satisfaction and Tolerability Study

    Not yet reported Bayer 145 participants Est. completion 2022-08-05 9 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03091595

    E4/DRSP Ovarian Function Inhibition Study

    Not yet reported Estetra 82 participants Est. completion 2018-06-08 1 site
    Other conditions: Prevention of Pregnancy
    View official trial listing →
  • Status unknown NCT NCT03111615

    HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

    Not yet reported Centro Hospitalar Lisboa Ocidental 90 participants Est. completion 2020-05-01 1 site
    Other conditions: Hormone Dependent Neoplasms, Breast Cancer Female
    View official trial listing →
  • Withdrawn NCT NCT03169764

    QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03169777

    QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03176238

    Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 235 participants Est. completion 2019-01-29 55 sites
    Other conditions: Post Menopausal Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03192293

    Metformin and Simvastatin in Addition to Fulvestrant

    Not yet reported National University Hospital, Singapore 28 participants Est. completion 2019-01-20 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03201913

    Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

    Not yet reported TTC Oncology, LLC 15 participants Est. completion 2020-04-30 4 sites
    Other conditions: Metastatic ER+ Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03202862

    The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer

    Not yet reported Fudan University 50 participants Est. completion 2019-08-01
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03240081

    Treating Postmenopausal Dyspareunia Where it Hurts

    Not yet reported Oregon Health and Science University 50 participants Est. completion 2019-11-21 1 site
    Other conditions: Dyspareunia
    View official trial listing →
  • Status unknown NCT NCT03240159

    Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

    Not yet reported Assisting Nature 120 participants Est. completion 2021-06-30 1 site
    Other conditions: Pregnancy, Ovarian
    View official trial listing →
  • Completed NCT NCT03250676

    Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer

    Not yet reported, Not yet reported Eisai Inc. 151 participants Est. completion 2023-10-26 39 sites
    Other conditions: Breast Neoplasms, Breast Cancer, Estrogen-receptor Positive Breast Cancer, Cancer, Breast, Breast Cancer Female, Breast Adenocarcinoma, Estrogen Receptor Positive Tumor, ER Positive
    View official trial listing →
  • Completed NCT NCT03262727

    The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

    Not yet reported Bristol-Myers Squibb 49 participants Est. completion 2017-12-19 1 site
    Other conditions: Systemic Lupus Erythematosus, Arthritic Psoriasis, Psoriasis, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03301233

    Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women

    Not yet reported Ain Shams University 90 participants Est. completion 2018-07-30 1 site Stand-alone
    Other conditions: Endometrial Thickness
    View official trial listing →
  • Completed NCT NCT03312738

    A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor

    Not yet reported Novartis Pharmaceuticals 159 participants Est. completion 2022-04-25 15 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT03321981

    MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

    Not yet reported Merus B.V. 105 participants Est. completion 2023-07-26 25 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03333564

    Effect of Vitamin D3 and Omega-3FA on Estradiol

    Not yet reported Applied Science Private University 116 participants Est. completion 2017-02
    Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT03336437

    Estrogen and the Urogenital Microbiome in GSM

    Not yet reported Oregon Health and Science University 40 participants Est. completion 2019-08-23 1 site
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT03373149

    Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

    Not yet reported Riyadh Fertility and Reproductive Health center 228 participants Est. completion 2020-11 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03394027

    ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

    Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2021-10-07 1 site Stand-alone
    Other conditions: Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03416764

    Estradiol-mediated Neural Plasticity as Potential Mediator of Neurofeedback Treatment Change for Traumatized Women

    Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2022-02-20 1 site Stand-alone
    Other conditions: Posttraumatic Stress Disorder (PTSD)
    View official trial listing →
  • Completed NCT NCT03426228

    In Vitro Fertilization Impact on Metabolic Parameters

    University of Warwick 344 participants Est. completion 2020-01-05 1 site
    Other conditions: GDM, Insulin Resistance, Glucose Intolerance, PCOS, Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT03452878

    Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients

    Hospital Sirio-Libanes 4 participants Est. completion 2026-12-31
    Other conditions: Aggression
    View official trial listing →
  • Completed NCT NCT03455270

    G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

    Not yet reported G1 Therapeutics, Inc. 107 participants Est. completion 2022-09-29 15 sites
    Other conditions: Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Neoplasm, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT03481998

    A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 104 participants Est. completion 2022-07-30 4 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT03505736

    Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

    Wake Forest University Health Sciences 25 participants Est. completion 2020-03-05 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Premenopausal, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT03547024

    A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol

    Not yet reported Janssen-Cilag International NV 14 participants Est. completion 2018-08-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03560856

    A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer

    Not yet reported Assistance Publique - Hôpitaux de Paris 54 participants Est. completion 2022-06-01
    Other conditions: Breast Cancer, HR+/HER2-negative Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT03578172

    HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 186 participants Est. completion 2019-11-20 1 site
    Other conditions: Infertility, Female, Intrauterine Adhesion
    View official trial listing →
  • Status unknown NCT NCT03584971

    Estrogen and Cooperation, Competitiveness, and Risk Preferences

    RWTH Aachen University 80 participants Est. completion 2021-12-30 1 site
    Other conditions: Behavioral Correlates of Estradiol
    View official trial listing →
  • Completed NCT NCT03608241

    A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)

    Not yet reported Pfizer 12 participants Est. completion 2018-11-23 2 sites
    Other conditions: Healthy Females
    View official trial listing →
  • Completed NCT NCT03620643

    Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

    Not yet reported Royal Marsden NHS Foundation Trust 33 participants Est. completion 2024-08-30 5 sites
    Other conditions: Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer, CDH1 Gene Mutation
    View official trial listing →
  • Completed NCT NCT03633331

    Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 93 participants Est. completion 2026-02-27 447 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Active, not recruiting NCT NCT03640624

    Multidisciplinary Treatment of Chronic Vulvar Pain

    Not yet reported Norwegian University of Science and Technology 106 participants Est. completion 2027-06 1 site
    Other conditions: Vulvodynia, Chronic Pain
    View official trial listing →
  • Completed NCT NCT03642665

    Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer

    Not yet reported Universitaire Ziekenhuizen KU Leuven 554 participants Est. completion 2024-11-01 1 site
    Other conditions: Embryo Transfer
    View official trial listing →
  • Status unknown NCT NCT03651427

    Cross-sex Hormone Therapy and Neuronal Plasticity

    Not yet reported Hospital de Clinicas de Porto Alegre 30 participants Est. completion 2019-03-30 1 site Stand-alone
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT03652623

    Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study

    Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 site
    Other conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
    View official trial listing →
  • Completed NCT NCT03663075

    Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women

    Not yet reported Vastra Gotaland Region 370 participants Est. completion 2020-11-06 1 site Stand-alone
    Other conditions: Women's Health, Quality of Life, Mental Health, Menopause, Primary Health Care, Sick Leave
    View official trial listing →
  • Completed NCT NCT03685331

    HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 Mutation
    View official trial listing →
  • Completed NCT NCT03703492

    Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

    Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2024-01-02 1 site Stand-alone
    Other conditions: Breast Cancer, Ductal Carcinoma in Situ - Category
    View official trial listing →
  • Active, not recruiting NCT NCT03725059

    Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

    Not yet reported Merck Sharp & Dohme LLC 1240 participants Est. completion 2031-01-24 244 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03725436

    ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors

    Not yet reported M.D. Anderson Cancer Center 28 participants Est. completion 2026-03-11 1 site
    Other conditions: Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Malignant Solid Neoplasm, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Recurrent Breast Carcinoma, TP53 wt Allele, Unresectable Malignant Solid Neoplasm
    View official trial listing →
  • Terminated NCT NCT03725696

    The Effect of Bariatric Surgery on Spermatogenesis

    The Cleveland Clinic 25 participants Est. completion 2020-12-31 1 site
    Other conditions: Bariatric Surgery Candidate, Sexual Function and Fertility Disorders
    View official trial listing →
  • Completed NCT NCT03726931

    FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

    Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03773263

    New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome

    Not yet reported Sun Yat-sen University 300 participants Est. completion 2020-03 5 sites
    Other conditions: Polycystic Ovary Syndrome, Infertility
    View official trial listing →
  • Completed NCT NCT03783897

    A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

    Not yet reported Enanta Pharmaceuticals, Inc 43 participants Est. completion 2019-06-18 1 site
    MASH
    View official trial listing →
  • Completed NCT NCT03786393

    Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome

    Nigde Omer Halisdemir University 200 participants Est. completion 2021-05-15 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT03809546

    Individual Differences in Drug Response

    Not yet reported University of Chicago 60 participants Est. completion 2021-06-01 1 site
    Other conditions: Differential Female Response to Δ9-tetrahydrocannabinol (THC)
    View official trial listing →
  • Completed NCT NCT03809988

    PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

    Not yet reported MedSIR 198 participants Est. completion 2022-11-30 53 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT03831711

    68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

    Not yet reported, Not yet reported Andrei Iagaru 5 participants Est. completion 2021-11-15 1 site
    Other conditions: Breast Carcinoma, Estrogen Receptor Positive
    View official trial listing →
  • Completed NCT NCT03832972

    Performance During Menstrual Cycle

    University of Aarhus 40 participants Est. completion 2022-04-01 1 site
    Other conditions: Performance
    View official trial listing →
  • Completed NCT NCT03843346

    The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

    Cancer Trials Ireland 87 participants Est. completion 2021-02-02 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03843736

    The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2020-12-31 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Withdrawn NCT NCT03846583

    Tucatinib + Abemaciclib + Herceptin for HER2+ MBC

    Not yet reported Dana-Farber Cancer Institute Est. completion 2020-09-22 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03856970

    Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

    Not yet reported Ironwood Pharmaceuticals, Inc. 87 participants Est. completion 2019-07-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03876145

    The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

    Not yet reported Royan Institute 120 participants Est. completion 2020-11-20 1 site
    Other conditions: Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT03887728

    Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles

    ART Fertility Clinics LLC 124 participants Est. completion 2020-12-14 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Status unknown NCT NCT03898401

    Effect of PRP Injection in Releiving of Symptoms of Senile Vaginitis

    Not yet reported Ain Shams University 30 participants Est. completion 2019-10-30 2 sites Stand-alone
    Other conditions: Senile Vaginitis
    View official trial listing →
  • Completed NCT NCT03926936

    FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

    Not yet reported Frederic Amant 17 participants Est. completion 2022-12-27 14 sites
    Obstructive sleep apnea Other conditions: Endometrial Stromal Sarcoma, Endometrial Cancer, Sex Cord Stromal Tumor, Serous Ovarian Tumor
    View official trial listing →
  • Terminated NCT NCT03943823

    Postmenopausal Pessary Users: Estrogen Versus Trimosan

    Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2021-04-08 1 site
    Other conditions: Vaginosis, Vaginosis, Bacterial, Vaginal Discharge
    View official trial listing →
  • Active, not recruiting NCT NCT03959891

    AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

    Not yet reported Massachusetts General Hospital 77 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03994432

    Effect of Mediterranean Diet and Physical Activity in Patients With Endometriosis

    Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 140 participants Est. completion 2023-11-20 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03998761

    Progesterone Versus Progesterone Plus Dydrogesterone in FET

    Not yet reported Mỹ Đức Hospital 1364 participants Est. completion 2021-01-31 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT04016753

    A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 32 participants Est. completion 2020-02-21 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT04033172

    Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant )

    Not yet reported Chinese Academy of Medical Sciences 40 participants Est. completion 2021-09-01 1 site
    Other conditions: Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04039204

    Elagolix for Fertility Enhancement Clinical Trial

    Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2023-08-09 1 site Stand-alone
    Other conditions: Endometriosis, Unexplained Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT04045379

    LASER and Radiofrequency and Genitourinary Syndrome of Menopause

    Not yet reported Federal University of São Paulo 195 participants Est. completion 2025-08 1 site
    Other conditions: Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms, Genitourinary Symptoms
    View official trial listing →
  • Completed NCT NCT04066283

    Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women

    University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Status unknown NCT NCT04152057

    Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

    Not yet reported, Not yet reported West China Hospital 20 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Breast Cancer, HER2 Positive, Combination Chemotherapy
    View official trial listing →
  • Completed NCT NCT04176757

    A Study of ZN-c5 in Participants With Breast Cancer

    Not yet reported Zeno Alpha Inc. 35 participants Est. completion 2021-05-25 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04192266

    Estrogen and Fear in PTSD

    Not yet reported The University of Texas Health Science Center, Houston 83 participants Est. completion 2024-12-02 2 sites Stand-alone
    Other conditions: PTSD
    View official trial listing →
  • Completed NCT NCT04272008

    The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

    Not yet reported TherapeuticsMD 21 participants Est. completion 2021-06-08 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT04294225

    Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

    Not yet reported Mayo Clinic 161 participants Est. completion 2022-12-12 3 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
    View official trial listing →
  • Terminated NCT NCT04296942

    BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)

    Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2021-10-22 1 site Stand-alone
    Other conditions: Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer, Hormone Receptor Negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04330677

    Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin

    Not yet reported University Hospital, Bonn 487 participants Est. completion 2020-01-25 1 site Stand-alone
    Other conditions: Oxytocin, Estrogen, Fear Extinction, Emotion Processing, Memory
    View official trial listing →
  • Completed NCT NCT04352777

    Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

    Not yet reported Duke University 18 participants Est. completion 2025-06-25 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor
    View official trial listing →
  • Status unknown NCT NCT04419727

    Estrogen Receptors and Peripheral Artery Disease

    University of Catanzaro 40 participants Est. completion 2020-11-02 1 site
    Other conditions: Estrogen Deficiency, Peripheral Artery Disease
    View official trial listing →
  • Withdrawn NCT NCT04487392

    Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.

    Not yet reported University of Nove de Julho Est. completion 2021-12-30
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT04508582

    Cardiac and Immune Cell Function in Preeclampsia

    Queen Mary University of London 86 participants Est. completion 2024-03-06 1 site
    Cardiovascular disease Other conditions: Preeclampsia, Hypertension, Pregnancy Induced Hypertension, Pregnancy Related, Cardiovascular Risk Factor, Heart Diseases
    View official trial listing →
  • Completed NCT NCT04531943

    Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

    Emory University 285 participants Est. completion 2024-04-04 1 site
    Other conditions: HIV Prevention
    View official trial listing →
  • Completed NCT NCT04544475

    A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

    Not yet reported NYU Langone Health 49 participants Est. completion 2022-10-03 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Completed NCT NCT04572295

    A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

    Not yet reported Eisai Co., Ltd. 51 participants Est. completion 2026-06-18 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04588298

    A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer

    Not yet reported AstraZeneca 135 participants Est. completion 2023-06-19 12 sites
    Other conditions: HER2-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04590417

    Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

    Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04713904

    Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 38 participants Est. completion 2021-02-02 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04714554

    A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

    Not yet reported Myovant Sciences GmbH 43 participants Est. completion 2021-03-29 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04822857

    The Impact of Menopause on the Development of Heart Failure and Organ Damage of Hypertension

    Polish Mother Memorial Hospital Research Institute 86 participants Est. completion 2020-12-30 1 site
    Other conditions: Hypertension, Menopause
    View official trial listing →
  • Status unknown NCT NCT04831151

    The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

    Not yet reported Inonu University 42 participants Est. completion 2023-06 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT04841499

    Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause

    Not yet reported University of South Alabama 40 participants Est. completion 2021-07-15 1 site
    Other conditions: Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT04862663

    Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

    Not yet reported AstraZeneca 893 participants Est. completion 2029-08-14 225 sites
    Other conditions: Locally Advanced (Inoperable) or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04923867

    Suturable DuraGen™ PMCF Study

    Integra LifeSciences Corporation 106 participants Est. completion 2024-07-31 3 sites
    Other conditions: Cerebrospinal Fluid Leak
    View official trial listing →
  • Status unknown NCT NCT04962386

    Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD

    Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2022-03-06 2 sites
    Other conditions: Meibomian Gland Dysfunction
    View official trial listing →
  • Terminated NCT NCT04965688

    Biology Guided Therapy for Breast Cancer for ER Positive

    Not yet reported Inova Health Care Services 2 participants Est. completion 2024-03-13 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05000736

    Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC

    Chinese Academy of Medical Sciences 600 participants Est. completion 2022-09-01 1 site
    Other conditions: Hormone Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05012644

    Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

    Pfizer 197 participants Est. completion 2021-12-09 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05021094

    Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction

    Not yet reported Affiliated Hospital of Nantong University 120 participants Est. completion 2023-12-31 6 sites Stand-alone
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Withdrawn NCT NCT05051293

    Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension

    Methodist Health System Est. completion 2024-08-17
    Other conditions: Hypotension, Cirrhosis
    View official trial listing →
  • Completed NCT NCT05054374

    A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 6 participants Est. completion 2023-10-26 4 sites Stand-alone
    Other conditions: Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer, Solid Carcinoma, MEK1 Gene Mutation, MEK2 Gene Mutation, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05076695

    Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer

    Not yet reported Fudan University 37 participants Est. completion 2024-10-15 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05080842

    A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

    Not yet reported Accutar Biotechnology Inc 21 participants Est. completion 2024-04-04 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05095597

    Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)

    Not yet reported Fundación IVI 15 participants Est. completion 2025-01-27 1 site Stand-alone
    Other conditions: Asherman Syndrome, Endometrial Atrophy
    View official trial listing →
  • Status unknown NCT NCT05133674

    Therapeutic Dose Monitoring (TDM) of Tamoxifen

    Not yet reported Karolinska University Hospital 40 participants Est. completion 2023-03-01 1 site
    Other conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Cancer of Breast, Malignant Neoplasm of Breast
    View official trial listing →
  • Completed NCT NCT05189873

    GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

    Not yet reported Tehran University of Medical Sciences 128 participants Est. completion 2022-01-03 1 site
    Other conditions: Polycystic Ovary Syndrome, Infertility, Female
    View official trial listing →
  • Active, not recruiting NCT NCT05226871

    Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

    Not yet reported Pfizer 35 participants Est. completion 2029-12-31 23 sites
    Other conditions: Breast Cancer, Head and Neck Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05238922

    Study of INCB123667 in Subjects With Advanced Solid Tumors

    Not yet reported Incyte Corporation 291 participants Est. completion 2027-08-31 41 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT05296798

    A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 922 participants Est. completion 2030-12-31 202 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05340010

    Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

    Not yet reported Alexandria University 180 participants Est. completion 2022-07-30 1 site Stand-alone
    Other conditions: hCG, FET, Frozen-thawed Embryo Transfe, Human Chorionic Gonadotrophin
    View official trial listing →
  • Status unknown NCT NCT05411380

    Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

    Not yet reported wang shusen 73 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05418426

    A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

    Not yet reported Daré Bioscience, Inc. 34 participants Est. completion 2022-01-27 2 sites
    Other conditions: Vulvovaginal Atrophy, Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT05448924

    Isolated Growth Hormone Deficiency and Amennorrhea

    Universitas Padjadjaran 1 participants Est. completion 2022-01-31 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT05458375

    Vaginal Estradiol Use in Pessary Care

    Not yet reported University of South Florida 11 participants Est. completion 2023-04-26 1 site Stand-alone
    Other conditions: Pelvic Organ Prolapse, Urinary Incontinence, Pessary Ulcer of Vagina, Vaginal Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT05463601

    Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05464654

    Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause

    Not yet reported Hospital Regional 1o de Octubre 136 participants Est. completion 2022-12-31 1 site
    Other conditions: Genitourinary Syndrome of Menopause, Postmenopausal Disorder, Menopause, Vagina Atrophy
    View official trial listing →
  • Completed NCT NCT05501769

    ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer

    Not yet reported Arvinas Estrogen Receptor, Inc. 32 participants Est. completion 2025-08-25 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05531357

    Physiologic Mechanisms Underlying Ovarian Follicular Waves During the Menstrual Cycle

    University of Saskatchewan 50 participants Est. completion 2024-03-26 1 site
    Other conditions: Reproductive Issues
    View official trial listing →
  • Completed NCT NCT05549505

    A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

    Not yet reported Arvinas Inc. 152 participants Est. completion 2024-07-25 49 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05579574

    A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 42 participants Est. completion 2023-06-01 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05613777

    A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 19 participants Est. completion 2023-10-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05724407

    Molecular Signature for Breast Cancer

    Assistance Publique - Hôpitaux de Paris 220 participants Est. completion 2023-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05788952

    The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometriosis

    Universidade Nova de Lisboa 60 participants Est. completion 2024-12-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT05801705

    Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 700 participants Est. completion 2023-12-30 1 site
    Other conditions: Hormone-receptor-positive Breast Cancer, Premenopausal Breast Cancer, Breast Cancer Patients at Intermediate to High Risk, Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or Torimefen
    View official trial listing →
  • Status unknown NCT NCT05802277

    Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.

    Not yet reported EZUS-LYON 1 130 participants Est. completion 2024-04-01 1 site
    Other conditions: Menstrual Cycle, Oral Contraceptive Use
    View official trial listing →
  • Completed NCT NCT05865262

    Protocol TRANS and QT Repolarization

    University Hospital, Bordeaux 120 participants Est. completion 2023-01-01 1 site
    Other conditions: Transgender Individuals, QTc Interval
    View official trial listing →
  • Withdrawn NCT NCT06058728

    A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

    AbbVie Est. completion 2026-08 1 site
    Other conditions: Uterine Fibroids (UF)
    View official trial listing →
  • Status unknown NCT NCT06067256

    A Multicentre, Prospective, Open-label, Non-comparative Study

    Not yet reported Italfarmaco 228 participants Est. completion 2024-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT06074055

    PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

    Not yet reported Reproductive Medicine Associates of New Jersey 9 participants Est. completion 2024-10-21 2 sites
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT06086340

    Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

    Pfizer 779 participants Est. completion 2024-01-24 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06109623

    Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women

    RenJi Hospital 1226 participants Est. completion 2023-12-01
    Other conditions: Urinary Incontinence,Stress
    View official trial listing →
  • Completed NCT NCT06136208

    Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women

    Not yet reported Science Valley Research Institute 20 participants Est. completion 2025-07-30 1 site
    Other conditions: Climacteric Syndrome, Menopause, Hypoestrogenism
    View official trial listing →
  • Completed NCT NCT06148129

    Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients

    Not yet reported Zagazig University 96 participants Est. completion 2022-03-01 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT06172322

    A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

    Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 42 participants Est. completion 2025-07 1 site
    Other conditions: HR Positive/HER-2 Negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06233058

    Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

    Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-27
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06250205

    Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

    Not yet reported NewAmsterdam Pharma 30 participants Est. completion 2024-04-26 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06316180

    The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation

    Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sites
    Other conditions: Endometrial Polyp, Endometrial Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06318403

    Estradiol Supplementation and Rotator Cuff Repair

    Not yet reported University of Utah 58 participants Est. completion 2030-12 Stand-alone
    Other conditions: Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome, Menopause Related Conditions, Menopause
    View official trial listing →
  • Status unknown NCT NCT06346457

    Breast Cancer & Antiestrogenic Therapy & Brain

    International Research Training Group 2804 180 participants Est. completion 2026-04-01 1 site
    Other conditions: Breast Cancer Female, Healthy Female, Menopause, Anti-estrogenic Therapy
    View official trial listing →
  • Completed NCT NCT06354257

    A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

    Not yet reported GlaxoSmithKline 20 participants Est. completion 2024-07-01 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT06396208

    "Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

    Not yet reported Chulalongkorn University 40 participants Est. completion 2024-10-20 1 site Stand-alone
    Other conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile
    View official trial listing →
  • Active, not recruiting NCT NCT06495164

    A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

    Pfizer 1 participants Est. completion 2026-12-30 1 site
    Other conditions: Breast Cancer, Malignant Neoplasm of Breast
    View official trial listing →
  • Completed NCT NCT06504953

    Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy

    Not yet reported Centre Hospitalier Universitaire de Nice 72 participants Est. completion 2026-06-17 1 site Stand-alone
    Other conditions: Women, Tibial Translation, Hormone
    View official trial listing →
  • Active, not recruiting NCT NCT06577987

    Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

    Not yet reported Circle Pharma 220 participants Est. completion 2027-03-14 10 sites
    Other conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor, Cancer, Lung Cancer, Triple Negative Breast Cancer, Breast Neoplasms, Neuroendocrine Tumors, Neuroendocrine Carcinoma, RB1 Gene Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT06623903

    Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy

    Aarhus University Hospital 112 participants Est. completion 2025-07-31 1 site
    Other conditions: Early Breast Cancer, Metabolic Health, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT06695039

    Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

    Not yet reported Asan Medical Center 71 participants Est. completion 2025-10-02 1 site
    Other conditions: Breast Cancer Invasive
    View official trial listing →
  • Active, not recruiting NCT NCT06715514

    Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes

    Not yet reported Lia Bally 96 participants Est. completion 2026-12-31 1 site
    Type 2 diabetes Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT06799884

    A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives

    Not yet reported Idorsia Pharmaceuticals Ltd. 19 participants Est. completion 2025-02-21 1 site
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Active, not recruiting NCT NCT06805084

    Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 80 participants Est. completion 2031-12 1 site
    Other conditions: Breast Adenocarcinoma, Luminal B Breast Cancer
    View official trial listing →
  • Completed NCT NCT06816355

    Exogenous Sex Hormones and PONV

    Riverside University Health System Medical Center 7348 participants Est. completion 2025-02-04 1 site
    Other conditions: Postoperative Nausea and Vomiting, Sex Hormone, Transgender
    View official trial listing →
  • Terminated NCT NCT06851442

    Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8 participants Est. completion 2025-11-20 17 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT06938711

    A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Context Therapeutics Inc. Est. completion 2023-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06963840

    Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

    Not yet reported Wellizen Australia 16 participants Est. completion 2025-08 1 site
    Other conditions: Polycystic Ovarian Syndrome (PCOS)
    View official trial listing →
  • Not yet recruiting NCT NCT07003373

    Comparison of Two Protocols in Frozen Embryo Transfer

    Not yet reported Malihe Mahmoudinia 112 participants Est. completion 2026-07-05 Stand-alone
    Other conditions: IVF Outcomes
    View official trial listing →
  • Not yet recruiting NCT NCT07021664

    Health, Imaging, and Cognition Across the Menopausal Transition

    Université de Sherbrooke 45 participants Est. completion 2026-07-01 1 site
    Other conditions: Menopause
    View official trial listing →
  • Withdrawn NCT NCT07038070

    Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

    Not yet reported NYU Langone Health Est. completion 2026-05-01 1 site Stand-alone
    Other conditions: Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Active, not recruiting NCT NCT07038369

    A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

    Not yet reported Atavistik Bio, Inc 134 participants Est. completion 2029-01-31 8 sites
    Other conditions: Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Neoplasms, ER Positive Breast Cancer, Cervical Cancers, Cervical Neoplasms, Cervical Carcinoma, Triple Negative Breast Cancer, Gynecologic Cancers, Gynecologic Neoplasm, Endometrial Cancer, Endometrial Neoplasm, Endometrial Carcinoma (EC), Fallopian Cancer, Ovarian Carcinoma, Ovarian Cancer, Ovarian Neoplasms, Prostate Cancers, Prostate Carcinoma, Solid Tumors, Neoplasms, Neoplasms by Site, Breast Diseases, Uterine Neoplasms, Genital Neoplasms, Female, Urogenital Neoplasms
    View official trial listing →
  • Completed NCT NCT07074327

    Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 74 participants Est. completion 2026-02-27 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Completed NCT NCT07190430

    A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

    Not yet reported Pfizer 16 participants Est. completion 2025-12-15 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Not yet recruiting NCT NCT07201259

    Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy

    West China Second University Hospital 40 participants Est. completion 2026-10-10 1 site
    Other conditions: Malignant Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT07204093

    Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 138 participants Est. completion 2026-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Not yet recruiting NCT NCT07212712

    The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

    Not yet reported University of British Columbia 50 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Cerebral Blood Flow, Cerebral Blood Flow Regulation, Sex Differences, Exercise, Vascular
    View official trial listing →
  • Not yet recruiting NCT NCT07235618

    A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 site
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07245316

    Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

    Not yet reported Jeong Eon Lee 340 participants Est. completion 2032-12-31 1 site
    Other conditions: Ductal Carcinoma in Situ of the Breast
    View official trial listing →
  • Not yet recruiting NCT NCT07378241

    Effects of Patients' Hormone Levels on Sedoanalgesia

    Izmir City Hospital 100 participants Est. completion 2026-04-30
    Other conditions: Consumption of Anaesthetic Agents, Sedoanalgesia
    View official trial listing →
  • Not yet recruiting NCT NCT07393321

    A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer

    Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 210 participants Est. completion 2031-08-31
    Other conditions: HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT07450300

    Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients

    Clinique Mathilde 1831 participants Est. completion 2026-01-31 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Not yet recruiting NCT NCT07480681

    Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

    Not yet reported Shanghai Henlius Biotech 138 participants Est. completion 2028-06
    Other conditions: Advanced/Metastatic Solid Tumors
    View official trial listing →
  • Completed NCT NCT07502417

    A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants

    Not yet reported AbbVie 15 participants Est. completion 2026-07-02 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Not yet recruiting NCT NCT07535905

    Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients

    Not yet reported University Health Network, Toronto 96 participants Est. completion 2030-10 1 site Stand-alone
    Other conditions: Hypogonadism, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT07581054

    Super-Resolution Ultrasound Microvascular Mapping for Non-Invasive Breast Cancer Molecular Subtyping: A Validated Nomogram

    Anhui Provincial Cancer Hospital 94 participants Est. completion 2026-01-26 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07618039

    MOving Forward With MENopause Treatment Through Pharmacists' Expanded Roles in Hormone Health

    Dalhousie University 200 participants Est. completion 2027-12-31
    Other conditions: Menopause, Pharmacists
    View official trial listing →
  • Not yet recruiting NCT NCT07618923

    Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer

    Not yet reported Tang-Du Hospital 20 participants Est. completion 2029-01
    Other conditions: Breast Cancer, HR Positive/HER2 Low Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07634601

    Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2029-12-18 1 site
    Other conditions: Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Cancer, Stage IV Endometrial Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07642700

    GnRH Agonist Pretreatment in Persistent Chronic Endometritis Undergoing FET

    Guoxia Yang 150 participants Est. completion 2028-06-01
    Other conditions: Chronic Endometritis
    View official trial listing →
  • Not yet recruiting NCT NCT07766369

    A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants

    Not yet reported Eisai Inc. 93 participants Est. completion 2026-11-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT07767474

    A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Antares Therapeutics, Inc 343 participants Est. completion 2030-01-31
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT07821086

    Effects of Estrogen Therapy on Lipid Metabolism and Insulin Sensitivity in Hypogonadal Women

    Not yet reported Khyber Medical University Peshawar 30 participants Est. completion 2026-09-20 1 site Stand-alone
    Other conditions: Female Hypogonadism
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Estrone, Estrogen, Arthcal ESTROGEN, BiEST 5.0 Estrogen Cream - 3.6oz, 3.6oz BiEST 2.5 Estrogen Cream, Bealions Estrogen, Estradiol Valerate

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.